Myriad Genetics to Present at the 21st Annual Piper Jaffray Health Care Conference
SALT LAKE CITY, Nov. 17, 2009 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that Peter D. Meldrum, President and CEO, is scheduled to present an overview of the Company at the 21st Annual Piper Jaffray...



